Biomind Labs Inc.
BMND
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -704.90K | -796.00K | -945.00K | -1.19M | -1.45M |
| Total Depreciation and Amortization | 6.60K | 6.60K | 12.60K | 15.20K | 23.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 275.70K | 329.10K | 227.20K | 181.90K | 140.40K |
| Change in Net Operating Assets | -39.30K | -26.80K | 79.40K | 229.40K | 400.20K |
| Cash from Operations | -461.80K | -487.00K | -625.70K | -766.00K | -889.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 328.50K | 501.40K | 582.70K | 770.80K | 665.00K |
| Total Debt Repaid | 1.00K | 1.00K | -200.00 | -8.20K | -17.60K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.10K | -- | -- | -- | -- |
| Cash from Financing | 324.40K | 502.40K | 582.50K | 762.50K | 647.30K |
| Foreign Exchange rate Adjustments | 18.60K | -43.10K | 31.10K | 1.50K | -34.20K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 44.50K | -- | -- |
| Net Change in Cash | -118.80K | -27.60K | 32.50K | -1.80K | -276.10K |